FDA issued a Warning Letter to Sunrise Pharmaceutical, Inc. on 1/14/2010 as a result of this inspection.
483 Sunrise Pharmaceutical Jul 2009

483 Sunrise Pharmaceutical Jul 2009

Atul Agrawal FDA, Joseph Mcginnis FDA, Addam Reynolds FDA$119.00 - Available Now

FDA investigators audited the Sunrise Pharmaceutical - Rahway, NJ, United States facility and issued inspectional observations (via FDA 483) on 17 Jul 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jul 2009
  • Location: Rahway, United States
  • FEI: 3004813394
Add To Cart